Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

The FDA Has Granted Breakthrough Therapy Designation To Bicara Therapeutics' Ficerafusp Alfa In Combination With Pembrolizumab For The First Line Treatment Of Patients With Metastatic Or With Unresectable, Recurrent Head And Neck Squamous Cell Carcinoma

Author: Benzinga Newsdesk | October 13, 2025 06:39am

Posted In: BCAX